Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,109 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical Outcomes of the CHIRP Trial: A Phase II Prospective Randomized Trial of Conventionally Fractionated Versus Moderately Hypofractionated Prostate and Pelvic Nodal Radiation Therapy in Patients With High-Risk Prostate Cancer.
Wang MH, Vos LJ, Yee D, Patel S, Pervez N, Parliament M, Usmani N, Danielson B, Amanie J, Pearcey R, Ghosh S, Field C, Fallone BG, Murtha AD. Wang MH, et al. Among authors: field c. Pract Radiat Oncol. 2021 Sep-Oct;11(5):384-393. doi: 10.1016/j.prro.2021.02.011. Epub 2021 Mar 9. Pract Radiat Oncol. 2021. PMID: 33705985 Clinical Trial.
Acute toxicity in high-risk prostate cancer patients treated with androgen suppression and hypofractionated intensity-modulated radiotherapy.
Pervez N, Small C, MacKenzie M, Yee D, Parliament M, Ghosh S, Mihai A, Amanie J, Murtha A, Field C, Murray D, Fallone G, Pearcey R. Pervez N, et al. Among authors: field c. Int J Radiat Oncol Biol Phys. 2010 Jan 1;76(1):57-64. doi: 10.1016/j.ijrobp.2009.01.048. Int J Radiat Oncol Biol Phys. 2010. PMID: 19395192 Clinical Trial.
Late Toxicity and Outcomes in High-risk Prostate Cancer Patients Treated With Hypofractionated IMRT and Long-term Androgen Suppression Treatment.
Pervez N, Boychak A, Drodge CS, Yee D, Le D, Murtha A, Parliament M, Amanie J, Mihai A, Field C, Mackenzie M, Ghosh S, Fallone G, Pearcey R. Pervez N, et al. Among authors: field c. Am J Clin Oncol. 2017 Apr;40(2):200-206. doi: 10.1097/COC.0000000000000133. Am J Clin Oncol. 2017. PMID: 25268067 Clinical Trial.
Conventional Versus Hypofractionated Radiation for High-Risk Prostate Cancer Patients (CHIRP): 24-Month Patient-Reported Outcomes of the Randomized Phase 2 CHIRP Trial.
Yang F, Ghosh S, Yee D, Patel S, Pervez N, Parliament M, Usmani N, Danielson B, Amanie J, Pearcey R, Field C, Fallone G, Murtha A. Yang F, et al. Among authors: field c. Int J Radiat Oncol Biol Phys. 2022 Sep 1;114(1):99-107. doi: 10.1016/j.ijrobp.2022.04.045. Epub 2022 May 7. Int J Radiat Oncol Biol Phys. 2022. PMID: 35537578 Clinical Trial.
Dosimetric effect of small bowel oral contrast on conventional radiation therapy, linear accelerator-based intensity modulated radiation therapy, and helical tomotherapy plans for rectal cancer.
Joseph K, Liu D, Severin D, Dickey M, Polkosnik LA, Warkentin H, Mihai A, Ghosh S, Field C. Joseph K, et al. Among authors: field c. Pract Radiat Oncol. 2015 Mar-Apr;5(2):e95-102. doi: 10.1016/j.prro.2014.07.004. Epub 2014 Sep 10. Pract Radiat Oncol. 2015. PMID: 25413403
1,109 results